Bradley Barnett, MD
Ophthalmology · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 14 years
- Johns Hopkins University School of Medicine, 2012
Offices
2 locations
Hospitals listed: Mercy General Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Barnett’s office at (916) 957-1515 to ask if they take your plan before you enroll.
California Medical Board record
Licence A154913 · Current
Licensed to practise in California · since 2018 · expires 2028-02-29 · Johns Hopkins University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Mercy General HospitalSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.43 (1.15 to 1.7), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 2.85 (2.2 to 3.51) · 4,531 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.124, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.18, Oct 2024 – Sep 2025
See every measure and the patient survey for Mercy General Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.43 (1.15 to 1.7) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 2.85 (2.2 to 3.51) · 4,531 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.124 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.18 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.82 (0 to 1.78) · 1,035 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.19 (116.89 to 215.48) · 113 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 142 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.2 · 70 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.2 · 431 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.8 · 348 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.2 · 242 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,346 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 5,509 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.06 to 0.45) · 6,091 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (1.01 to 4.84) · 1,995 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.42 (0.01 to 2.83) · 863 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.86 (0.49 to 3.22) · 1,834 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.67 (1.97 to 11.37) · 927 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 2.8 (0 to 5.97) · 914 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.06) · 331 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 171 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.457 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.426 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.904 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.306 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 902 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 642 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 10.6 · 513 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 23.5 · 445 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.5 · 229 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.2 · 349 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.7 · 168 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 295 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.4 · 175 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.3 to 16.4) · 405 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 516 cases | No different | Jan 2024 – Dec 2024 |
What patients said (477 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$187,854
Medicare paid this office $187,854 for 330 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Complex removal of cataract with insertion of prosthetic lens | 43 | $33,498 | $558 |
| Removal of recurring cataract in lens capsule using a laser | 59 | $29,765 | $276 |
| Established patient complete exam of visual system | 172 | $29,348 | $94 |
| Removal of cataract with insertion of prosthetic lens | 46 | $21,620 | $360 |
| New patient complete exam of visual system | 163 | $15,954 | $98 |
See all 13 services
| Complex removal of cataract with insertion of prosthetic lens | 43 | $33,498 | $558 |
| Removal of recurring cataract in lens capsule using a laser | 59 | $29,765 | $276 |
| Established patient complete exam of visual system | 172 | $29,348 | $94 |
| Removal of cataract with insertion of prosthetic lens | 46 | $21,620 | $360 |
| New patient complete exam of visual system | 163 | $15,954 | $98 |
| Established patient problem focused exam of visual system | 83 | $11,639 | $76 |
| Ct scan of cornea | 198 | $8,600 | $28 |
| Imaging of retina | 191 | $6,198 | $28 |
| Measurement of corneal curvature and depth of eye | 121 | $5,617 | $23 |
| Photography of content of eyes | 118 | $3,731 | $19 |
| Imaging of optic nerve | 39 | $1,398 | $26 |
| Exam of the internal drainage system of eye | 39 | $1,307 | $22 |
| Exam of visual field with extended testing | 21 | $1,057 | $44 |
Procedures Medicare counted
| Cataract surgery | 108 | More than 75% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of cataract with insertion of prosthetic lens | – | 31 | 116 | 107 | 84 | 60 |
| Removal of recurring cataract in lens capsule using a laser | – | – | 63 | 67 | 61 | 108 |
| Complex removal of cataract with insertion of prosthetic lens | – | – | 30 | 28 | 31 | 60 |
| Dilation of fluid outflow drainage within eye | – | – | – | 22 | – | – |
| Removal of excessive skin and fat of upper eyelid | – | – | – | – | 11 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
330 Original Medicare patients in 2024. Average age 74 · Under 65 4% · 85 and older 7% · Women 63% · Also on Medicaid 13% · Health risk score 0.97. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 67% · Diabetes 28% · Chronic kidney disease 20% · Coronary heart disease 16% · Cancer 15% · Depression 15% · Atrial fibrillation 14% · COPD 8% · Heart failure 7% · Stroke 7%.
The office billed $832,531, Medicare allowed $257,565 and paid $187,854; for 2,054 services of 42 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 330 | 2,054 | 74 | 0.97 | $832,531 | $187,854 |
| 2023 | 273 | 1,690 | 75 | 1.11 | $737,298 | $176,053 |
| 2022 | 219 | 1,320 | 75 | 0.94 | $741,282 | $137,336 |
| 2021 | 690 | 1,445 | 76 | 1.16 | $627,865 | $167,933 |
| 2020 | 534 | 1,273 | 74 | 1.30 | $422,615 | $119,743 |
| 2019 | 160 | 416 | 74 | 1.70 | $233,233 | $35,856 |
| 2018 | 64 | 103 | 73 | 1.49 | $62,523 | $9,529 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Removal of cataract with insertion of prosthetic lens | 58 | $30,967 | $369 |
| Established patient complete exam of visual system | 134 | $25,032 | $97 |
| Complex removal of cataract with insertion of prosthetic lens | 26 | $17,727 | $572 |
| New patient complete exam of visual system | 149 | $16,507 | $111 |
| Removal of recurring cataract in lens capsule using a laser | 48 | $16,316 | $267 |
| Removal of excessive skin and fat of upper eyelid | 11 | $8,700 | $791 |
| Measurement of corneal curvature and depth of eye | 127 | $6,869 | $24 |
| Ct scan of cornea | 125 | $4,896 | $30 |
| Established patient problem focused exam of visual system | 50 | $4,557 | $64 |
| Imaging of retina | 128 | $4,465 | $30 |
| Photography of content of eyes | 73 | $1,881 | $17 |
| Imaging of optic nerve | 28 | $1,404 | $30 |
| Exam of the internal drainage system of eye | 31 | $1,077 | $22 |
| Exam of visual field with intermediate testing | 18 | $655 | $27 |
| Ultrasound scan of cornea to determine thickness | 16 | $151 | $9 |
2022: 14 services
| Removal of cataract with insertion of prosthetic lens | 73 | $37,783 | $353 |
| Removal of recurring cataract in lens capsule using a laser | 54 | $18,322 | $273 |
| New patient complete exam of visual system | 171 | $17,310 | $101 |
| Complex removal of cataract with insertion of prosthetic lens | 21 | $14,311 | $511 |
| Dilation of fluid outflow drainage within eye | 15 | $13,764 | $626 |
| Measurement of corneal curvature and depth of eye | 122 | $7,254 | $22 |
| Established patient complete exam of visual system | 56 | $6,732 | $100 |
| Ct scan of cornea | 124 | $4,169 | $27 |
| Established patient problem focused exam of visual system | 33 | $3,333 | $72 |
| Imaging of retina | 52 | $1,949 | $31 |
| Ultrasound scan of cornea to determine thickness | 104 | $1,033 | $9 |
| Exam of the internal drainage system of eye | 23 | $813 | $23 |
| Imaging of optic nerve | 20 | $715 | $29 |
| Photography of content of eyes | 35 | $700 | $19 |
2021: 14 services
| Removal of cataract with insertion of prosthetic lens | 91 | $46,462 | $401 |
| Established patient problem focused exam of visual system | 289 | $19,254 | $52 |
| Established patient complete exam of visual system | 244 | $18,672 | $75 |
| Removal of recurring cataract in lens capsule using a laser | 54 | $16,877 | $268 |
| Complex removal of cataract with insertion of prosthetic lens | 23 | $16,714 | $557 |
| New patient complete exam of visual system | 125 | $12,933 | $103 |
| Measurement of corneal curvature and depth of eye | 70 | $3,250 | $29 |
| Return visit (30+ min) | 34 | $3,038 | $84 |
| Imaging of optic nerve | 102 | $2,490 | $24 |
| Exam of visual field with extended testing | 60 | $2,316 | $38 |
| Short return visit (20+ min) | 20 | $1,258 | $55 |
| Imaging of retina | 34 | $1,100 | $30 |
| Photography of the retina | 16 | $490 | $31 |
| Ct scan of cornea | 14 | $383 | $27 |
2020: 13 services
| Established patient complete exam of visual system | 338 | $32,242 | $93 |
| Established patient problem focused exam of visual system | 177 | $14,762 | $69 |
| Removal of cataract with insertion of prosthetic lens | 20 | $14,143 | $456 |
| New patient complete exam of visual system | 78 | $8,187 | $105 |
| Imaging of optic nerve | 107 | $3,226 | $30 |
| Measurement of corneal curvature and depth of eye | 48 | $2,675 | $34 |
| Exam of visual field with extended testing | 44 | $2,295 | $52 |
| Microfluid analysis of tears | 27 | $1,501 | $22 |
| Photography of the retina | 36 | $1,344 | $36 |
| Imaging of retina | 41 | $1,307 | $31 |
| Analysis of substance using immunoassay technique, multiple step method | 26 | $736 | $11 |
| Ct scan of cornea | 19 | $471 | $21 |
| Photography of content of eyes | 29 | $347 | $9 |
2019: 9 services
| Established patient complete exam of visual system | 58 | $5,951 | $94 |
| New patient complete exam of visual system | 42 | $4,466 | $106 |
| Established patient problem focused exam of visual system | 52 | $4,332 | $68 |
| Microfluid analysis of tears | 19 | $925 | $22 |
| Measurement of corneal curvature and depth of eye | 17 | $829 | $24 |
| Analysis of substance using immunoassay technique, multiple step method | 18 | $477 | $13 |
| Imaging of retina | 11 | $372 | $34 |
| Imaging of optic nerve | 13 | $351 | $27 |
| Photography of content of eyes | 18 | $330 | $16 |
2018: 1 service
| Established patient problem focused exam of visual system | 38 | $3,797 | $73 |
Medicaid work
$688 in 2024
Medicaid paid $688 for 117 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 60 | $420 |
| COMPUTERIZED CORNEAL TOPOGRAPHY UNI/BI W/I&R | 57 | $268 |
| 2024 | 117 | 2 | 17 | $688 |
| 2022 | 14 | 1 | 14 | $974 |
| 2020 | 209 | 5 | 73 | $137 |
See the largest Medicaid services in earlier years
2022
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 14 | $974 |
2020
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 123 | $103 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 40 | $33 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 12 | $0 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 18 | $0 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 16 | $0 |
Drugs they prescribed that Part D paid
$349,141
Pharmacies billed $349,141 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,685) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
678 generic and 1,007 brand-name prescriptions · $349,141 in drug cost · 14 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 161 | $106,685 | $663 |
| Cyclosporine | 302 | $89,128 | $295 |
| Xiidra | 104 | $83,930 | $807 |
| Prednisolone Acetate | 345 | $14,295 | $41 |
| Vevye | 16 | $12,020 | $751 |
See all 13 drugs
| Restasis | 161 | $106,685 | $663 |
| Cyclosporine | 302 | $89,128 | $295 |
| Xiidra | 104 | $83,930 | $807 |
| Prednisolone Acetate | 345 | $14,295 | $41 |
| Vevye | 16 | $12,020 | $751 |
| Erythromycin | 412 | $3,887 | $9 |
| Valacyclovir | 18 | $1,506 | $84 |
| Acetazolamide | 36 | $1,114 | $31 |
| Latanoprost | 80 | $649 | $8 |
| Neomycin-Polymyxin-Dexameth | 43 | $527 | $12 |
| Doxycycline Hyclate | 20 | $460 | $23 |
| Moxifloxacin | 14 | $299 | $21 |
| Timolol Maleate | 22 | $89 | $4 |
Year by year
| 2024 | 1,685 | 358 | 0% (0) | 60% | $349,141 |
| 2023 | 971 | 239 | None | 60% | $213,405 |
| 2022 | 908 | 287 | None | 51% | $162,169 |
| 2021 | 3,375 | 758 | 0% (0) | 59% | $938,261 |
| 2020 | 1,596 | 473 | None | 52% | $299,422 |
| 2019 | 553 | 188 | 0% (0) | 41% | $71,102 |
| 2018 | 382 | 106 | None | 37% | $26,821 |
| 2017 | 485 | 136 | None | 31% | $23,351 |
| 2016 | 155 | 44 | None | 26% | $6,175 |
| 2015 | 197 | 60 | None | 30% | $8,778 |
| 2014 | 118 | 57 | 12% (14) | 17% | $5,550 |
| 2013 | 37 | 14 | None | None | $2,077 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Cyclosporine | 99 | $49,070 | $496 |
| Xiidra | 55 | $48,581 | $883 |
| Restasis | 58 | $47,568 | $820 |
| Cequa | 33 | $20,963 | $635 |
| Prednisolone Acetate | 248 | $12,898 | $52 |
| Restasis Multidose | 12 | $8,415 | $701 |
| Erythromycin | 217 | $3,082 | $14 |
| Latanoprost | 51 | $1,188 | $23 |
| Acetazolamide | 25 | $1,075 | $43 |
| Doxycycline Hyclate | 16 | $803 | $50 |
| Neomycin-Polymyxin-Dexameth | 49 | $758 | $15 |
| Moxifloxacin | 14 | $455 | $32 |
| Cephalexin | 24 | $264 | $11 |
2022: 12 drugs
| Xiidra | 86 | $69,782 | $811 |
| Cequa | 46 | $30,745 | $668 |
| Restasis | 21 | $18,603 | $886 |
| Prednisolone Acetate | 205 | $11,848 | $58 |
| Lumigan | 16 | $5,278 | $330 |
| Erythromycin | 196 | $3,549 | $18 |
| Moxifloxacin | 82 | $2,356 | $29 |
| Latanoprost | 59 | $2,082 | $35 |
| Ketorolac Tromethamine | 76 | $1,726 | $23 |
| Doxycycline Hyclate | 16 | $1,018 | $64 |
| Dorzolamide-Timolol | 14 | $306 | $22 |
| Neomycin-Polymyxin-Dexameth | 20 | $284 | $14 |
2021: 17 drugs
| Xiidra | 947 | $695,559 | $734 |
| Restasis | 88 | $87,666 | $996 |
| Lumigan | 100 | $35,396 | $354 |
| Prednisolone Acetate | 474 | $27,807 | $59 |
| Combigan | 57 | $17,949 | $315 |
| Erythromycin | 789 | $16,552 | $21 |
| Latanoprost | 432 | $12,857 | $30 |
| Travoprost | 27 | $7,175 | $266 |
| Travatan Z | 17 | $4,889 | $288 |
| Doxycycline Hyclate | 57 | $3,647 | $64 |
| Moxifloxacin | 73 | $2,836 | $39 |
| Ketorolac Tromethamine | 65 | $1,372 | $21 |
| Dorzolamide-Timolol | 34 | $1,252 | $37 |
| Timolol Maleate | 89 | $1,127 | $13 |
| Valacyclovir | 18 | $1,016 | $56 |
| Pilocarpine | 12 | $794 | $66 |
| Dorzolamide | 15 | $774 | $52 |
2020: 17 drugs
| Xiidra | 272 | $184,312 | $678 |
| Lotemax | 64 | $24,410 | $381 |
| Prednisolone Acetate | 263 | $13,062 | $50 |
| Doxycycline Hyclate | 146 | $10,856 | $74 |
| Erythromycin | 314 | $6,673 | $21 |
| Valacyclovir | 45 | $6,650 | $148 |
| Rhopressa | 23 | $6,364 | $277 |
| Lumigan | 21 | $5,576 | $266 |
| Combigan | 17 | $4,545 | $267 |
| Fluorometholone | 54 | $4,007 | $74 |
| Moxifloxacin | 52 | $2,985 | $57 |
| Dorzolamide-Timolol | 20 | $2,152 | $108 |
| Latanoprost | 79 | $2,102 | $27 |
| Ketorolac Tromethamine | 40 | $920 | $23 |
| Ofloxacin | 43 | $809 | $19 |
| Timolol Maleate | 24 | $478 | $20 |
| Olopatadine | 14 | $472 | $34 |
2019: 12 drugs
| Lotemax | 58 | $20,446 | $353 |
| Xiidra | 13 | $8,224 | $633 |
| Rhopressa | 21 | $6,567 | $313 |
| Prednisolone Acetate | 62 | $3,949 | $64 |
| Doxycycline Hyclate | 65 | $3,545 | $55 |
| Pazeo | 16 | $3,177 | $199 |
| Valacyclovir | 30 | $2,676 | $89 |
| Moxifloxacin | 30 | $2,140 | $71 |
| Erythromycin | 87 | $1,575 | $18 |
| Ofloxacin | 37 | $852 | $23 |
| Latanoprost | 25 | $406 | $16 |
| Timolol Maleate | 16 | $204 | $13 |
2018: 9 drugs
| Lotemax | 14 | $5,125 | $366 |
| Prednisolone Acetate | 39 | $2,539 | $65 |
| Erythromycin | 56 | $1,117 | $20 |
| Latanoprost | 60 | $898 | $15 |
| Dorzolamide-Timolol | 31 | $464 | $15 |
| Doxycycline Hyclate | 11 | $337 | $31 |
| Ofloxacin | 18 | $308 | $17 |
| Brimonidine | 25 | $225 | $9 |
| Levobunolol | 16 | $131 | $8 |
2017: 8 drugs
| Prednisolone Acetate | 74 | $4,791 | $65 |
| Latanoprost | 86 | $1,471 | $17 |
| Dorzolamide-Timolol | 57 | $1,150 | $20 |
| Ofloxacin | 35 | $693 | $20 |
| Erythromycin | 55 | $667 | $12 |
| Brimonidine | 42 | $575 | $14 |
| Ketorolac Tromethamine | 18 | $410 | $23 |
| Timolol Maleate | 15 | $94 | $6 |
2016: 5 drugs
| Latanoprost | 33 | $482 | $15 |
| Dorzolamide | 15 | $466 | $31 |
| Brimonidine | 12 | $307 | $26 |
| Erythromycin | 19 | $228 | $12 |
| Timolol Maleate | 17 | $79 | $5 |
2015: 5 drugs
| Travatan Z | 17 | $2,556 | $150 |
| Dorzolamide-Timolol | 46 | $813 | $18 |
| Brimonidine | 13 | $495 | $38 |
| Latanoprost | 44 | $479 | $11 |
| Timolol Maleate | 18 | $169 | $9 |
Money from drug and device companies
$2,201 in 2025
| 2025 | 12 | 61 | $510 | $2,201 |
| 2024 | 12 | 62 | $701 | $2,579 |
| 2023 | 11 | 37 | $1,350 | $2,520 |
| 2022 | 12 | 61 | None | $1,935 |
| 2021 | 14 | 37 | None | $1,542 |
| 2020 | 6 | 8 | $500 | $724 |
| 2019 | 2 | 2 | None | $249 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Mallinckrodt Hospital Products | Acthar | $754 | 26 payments
|
| Rayner Intraocular Lenses | Omidria | $540 | 3 payments
|
| Alcon Vision | Tryptyr | $375 | 12 payments
|
| Biotissue Holdings | None | $155 | 5 payments
|
| Harrow Eye | Vevye | $146 | 6 payments
|
| Sight Sciences | Omni Surgical System | $44 | 2 payments
|
See all 61 published payments
| Mallinckrodt Hospital Products | Meals · 2025-12-23 | Acthar | $27 |
| Alcon Vision | Meals · 2025-12-19 | Tryptyr | $8 |
| Mallinckrodt Hospital Products | Meals · 2025-12-15 | Acthar | $50 |
| Bausch & Lomb Americas | Meals · 2025-12-15 | Scoutpro Osmolarity System | $20 |
| Mallinckrodt Hospital Products | Meals · 2025-12-09 | Acthar | $26 |
| Harrow Eye | Meals · 2025-12-04 | Vevye | $30 |
| Biotissue Holdings | Meals · 2025-11-26 | None | $28 |
| Mallinckrodt Hospital Products | Meals · 2025-11-25 | Acthar | $13 |
| Harrow Eye | Meals · 2025-11-21 | Vevye | $31 |
| Mallinckrodt Hospital Products | Meals · 2025-11-13 | Acthar | $24 |
| Alcon Vision | Meals · 2025-11-05 | Tryptyr | $122 |
| Biotissue Holdings | Meals · 2025-10-30 | None | $11 |
| Harrow Eye | Meals · 2025-10-27 | Vevye | $24 |
| Mallinckrodt Hospital Products | Meals · 2025-10-24 | Acthar | $28 |
| Johnson & Johnson Surgical Vision | Meals · 2025-10-14 | Tecnis Iol | $33 |
| Alcon Vision | Meals · 2025-10-14 | Tryptyr | $34 |
| Biotissue Holdings | Meals · 2025-09-30 | None | $81 |
| Mallinckrodt Hospital Products | Meals · 2025-09-26 | Acthar | $17 |
| Harrow Eye | Meals · 2025-09-26 | Vevye | $12 |
| Mallinckrodt Hospital Products | Meals · 2025-09-20 | Acthar | $26 |
| Alcon Vision | Meals · 2025-09-16 | Tryptyr | $12 |
| RxSight | Meals · 2025-09-16 | Rxsight Injector Handpiece | $32 |
| Biotissue Holdings | Meals · 2025-09-10 | None | $13 |
| Alcon Vision | Meals · 2025-09-04 | Wavelight Sightmap | $31 |
| Harrow Eye | Meals · 2025-09-03 | Flarex | $18 |
| Alcon Vision | Meals · 2025-08-28 | Tryptyr | $44 |
| Bausch & Lomb Americas | Meals · 2025-08-26 | Miebo | $21 |
| Biotissue Holdings | Meals · 2025-08-22 | None | $22 |
| Mallinckrodt Hospital Products | Meals · 2025-08-19 | Acthar | $30 |
| Alcon Vision | Meals · 2025-08-08 | Tryptyr | $14 |
| Mallinckrodt Hospital Products | Meals · 2025-08-08 | Acthar | $37 |
| Sun Pharmaceutical Industries | Meals · 2025-08-01 | Cequa | $26 |
| Mallinckrodt Hospital Products | Meals · 2025-07-23 | Acthar | $26 |
| Alcon Vision | Meals · 2025-07-18 | Tryptyr | $7 |
| Mallinckrodt Hospital Products | Meals · 2025-07-17 | Acthar | $28 |
| Harrow Eye | Meals · 2025-07-15 | Vevye | $32 |
| Rayner Intraocular Lenses | Consulting · 2025-06-30 | Omidria | $510 |
| Mallinckrodt Hospital Products | Meals · 2025-06-30 | Acthar | $12 |
| Alcon Vision | Meals · 2025-06-25 | Wavelight Ex500 Excimer Laser | $32 |
| Alcon Vision | Meals · 2025-06-25 | Wavelight Ex500 Excimer Laser | $26 |
| Mallinckrodt Hospital Products | Meals · 2025-06-19 | Acthar | $93 |
| Mallinckrodt Hospital Products | Meals · 2025-06-18 | Acthar | $19 |
| Mallinckrodt Hospital Products | Meals · 2025-05-30 | Acthar | $35 |
| Alcon Vision | Meals · 2025-05-19 | None | $24 |
| Sight Sciences | Meals · 2025-05-15 | Omni Surgical System | $19 |
| Mallinckrodt Hospital Products | Meals · 2025-05-08 | Acthar | $31 |
| Mallinckrodt Hospital Products | Meals · 2025-04-24 | Acthar | $31 |
| Mallinckrodt Hospital Products | Meals · 2025-04-10 | Acthar | $22 |
| Alcon Vision | Meals · 2025-04-02 | Hydrus Microstent | $23 |
| Mallinckrodt Hospital Products | Meals · 2025-03-27 | Acthar | $24 |
| Dompe US | Meals · 2025-03-17 | Oxervate | $23 |
| Mallinckrodt Hospital Products | Meals · 2025-03-13 | Acthar | $31 |
| Mallinckrodt Hospital Products | Meals · 2025-02-25 | Acthar | $34 |
| Mallinckrodt Hospital Products | Meals · 2025-02-19 | Acthar | $19 |
| Sight Sciences | Meals · 2025-02-10 | Omni Surgical System | $25 |
| Mallinckrodt Hospital Products | Meals · 2025-02-06 | Acthar | $35 |
| Rayner Intraocular Lenses | Meals · 2025-02-03 | Rayner Cataract Set 1 | $5 |
| Rayner Intraocular Lenses | Meals · 2025-01-31 | Rayner Cataract Set 1 | $26 |
| Mallinckrodt Hospital Products | Meals · 2025-01-31 | Acthar | $14 |
| Mallinckrodt Hospital Products | Meals · 2025-01-21 | Acthar | $21 |
| Merz North America | Meals · 2025-01-10 | None | $31 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,579
| Abbvie | Durysta | $961 | 10 payments
|
| Mallinckrodt Hospital Products | Acthar | $496 | 23 payments
|
| RxSight | Rxsight Contact Lens | $406 | 6 payments
|
| Alcon Vision | Wavelight Refractive Suite | $193 | 3 payments
|
| Harrow Eye | Vevye | $146 | 4 payments
|
| Bausch & Lomb Americas | Scoutpro Osmolarity System | $137 | 6 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $71 | 3 payments
|
| Amgen | Tepezza | $58 | 3 payments
|
| Beaver-Visitec International | None | $53 | 1 payment
|
| Merz North America | Xeomin | $22 | 1 payment
|
| Sight Sciences | Omni Surgical System | $18 | 1 payment
|
| Rayner Intraocular Lenses | Omidria | $18 | 1 payment
|
2023: $2,520
| AbbVie | Durysta | $1,581 | 7 payments
|
| Mallinckrodt Hospital Products | Acthar | $235 | 6 payments
|
| Sun Pharmaceutical Industries | Cequa | $148 | 10 payments
|
| Horizon Therapeutics plc | Tepezza | $132 | 2 payments
|
| Johnson & Johnson Vision Care | Acuvue | $131 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $91 | 3 payments
|
| Sight Sciences | Tearcare System | $59 | 2 payments
|
| Optos | Nfc-700 | $48 | 1 payment
|
| Beaver-Visitec International | None | $39 | 2 payments
|
| Alcon Vision | Rocklatan | $38 | 2 payments
|
| Bausch & Lomb Americas | Miebo | $18 | 1 payment
|
2022: $1,935
| Sight Sciences | Omni(R) Surgical System (US) | $660 | 19 payments
|
| Sun Pharmaceutical Industries | Cequa | $312 | 18 payments
|
| Johnson & Johnson Vision Care | Acuvue | $252 | 2 payments
|
| Alcon Vision | Precision 1 | $236 | 7 payments
|
| Johnson & Johnson Surgical Vision | Tecnis Simplicity | $158 | 4 payments
|
| Allergan | Vuity | $94 | 1 payment
|
| Abbvie | Durysta | $73 | 4 payments
|
| Novartis Pharmaceuticals | Xiidra | $56 | 2 payments
|
| Carl Zeiss Meditec USA | Lumera 700 | $39 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $22 | 1 payment
|
| Rayner Intraocular Lenses | Omidria | $19 | 1 payment
|
| BioTissue Holdings | Prokera | $15 | 1 payment
|
2021: $1,542
| Novartis Pharmaceuticals | Xiidra | $274 | 13 payments
|
| Johnson & Johnson Vision Care | Acuvue | $225 | 2 payments
|
| Sight Sciences | Tearcare Smartlid | $222 | 5 payments
|
| Glaukos | Istent Inject W | $145 | 3 payments
|
| Dompe US | Oxervate | $126 | 2 payments
|
| Alcon Vision | Precision 1 | $126 | 3 payments
|
| Aerie Pharmaceuticals | Rocklatan | $108 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $90 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $73 | 1 payment
|
| RxSight | Light Adjustable Lens (Lal) and Light Delivery Device (Ldd) | $69 | 1 payment
|
| Ivantis | Hydrus Microstent | $24 | 1 payment
|
| Beaver-Visitec International | None | $22 | 1 payment
|
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $21 | 1 payment
|
| Kala Pharmaceuticals | Inveltys | $16 | 1 payment
|
2020: $724
| Allergan | Durysta | $537 | 3 payments
|
| Alcon Vision | Acrysof Iq Panoptix | $97 | 1 payment
|
| Glaukos | Photrexa | $33 | 1 payment
|
| Sun Pharmaceutical Industries | Xelpros | $25 | 1 payment
|
| Kala Pharmaceuticals | Inveltys | $18 | 1 payment
|
| TissueTech | Prokera | $14 | 1 payment
|
2019: $249
| Kala Pharmaceuticals | Inveltys | $125 | 1 payment
|
| Shire North American Group | Xiidra | $124 | 1 payment
|
Professional record
- NPI
- 1154765139
- Licence
- CA A154913California A154913: Current · expires 2028-02-29
- Trained
- Johns Hopkins University School of Medicine, 2012 · 14 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA S3488511
- Taxonomy
- Federal specialty code 207WX0120X (207WX0120X); Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 3278 Southerland Rd, West Sacramento, CA, 95691
- NPI first listed
- 2013-04-22
- NPI last updated
- 2021-09-20
- NPI record certified
- 2021-09-20
This is when the NPI record was last certified, not a medical board exam.